Daniel Perez‐Zsolt

881 total citations
17 papers, 348 citations indexed

About

Daniel Perez‐Zsolt is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Daniel Perez‐Zsolt has authored 17 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 7 papers in Immunology and 6 papers in Epidemiology. Recurrent topics in Daniel Perez‐Zsolt's work include SARS-CoV-2 and COVID-19 Research (5 papers), Immunotherapy and Immune Responses (5 papers) and HIV Research and Treatment (4 papers). Daniel Perez‐Zsolt is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Immunotherapy and Immune Responses (5 papers) and HIV Research and Treatment (4 papers). Daniel Perez‐Zsolt collaborates with scholars based in Spain, Netherlands and Brazil. Daniel Perez‐Zsolt's co-authors include Nuria Izquierdo‐Useros, Javier Martínez‐Picado, Bonaventura Clotet, Jordana Muñoz‐Basagoiti, Dàlia Raϊch‐Regué, Julià Blanco, Itziar Erkizia, Ignacio Blanco, Susana Benet and Vanessa Blanc and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and The Lancet Infectious Diseases.

In The Last Decade

Daniel Perez‐Zsolt

17 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Perez‐Zsolt Spain 11 152 108 100 48 44 17 348
Prasanna Bhat India 12 71 0.5× 238 2.2× 72 0.7× 15 0.3× 10 0.2× 25 433
Fatima Barmania South Africa 4 192 1.3× 67 0.6× 74 0.7× 3 0.1× 36 0.8× 5 298
Marshall Karpel United States 5 89 0.6× 55 0.5× 106 1.1× 2 0.0× 55 1.3× 6 288
Anjali Singh India 14 231 1.5× 102 0.9× 246 2.5× 6 0.1× 364 8.3× 60 636
Ramona Businger Germany 12 87 0.6× 63 0.6× 106 1.1× 3 0.1× 54 1.2× 18 268
Ralf Duerr United States 9 206 1.4× 58 0.5× 48 0.5× 2 0.0× 104 2.4× 35 295
Frances Ayres South Africa 5 660 4.3× 181 1.7× 79 0.8× 2 0.0× 15 0.3× 8 729
Inesa Hyseni Italy 6 488 3.2× 124 1.1× 58 0.6× 3 0.1× 6 0.1× 6 554
Isabel Pagani Italy 10 187 1.2× 54 0.5× 66 0.7× 2 0.0× 24 0.5× 23 346
Jialu Zhang China 6 296 1.9× 87 0.8× 63 0.6× 2 0.0× 6 0.1× 30 371

Countries citing papers authored by Daniel Perez‐Zsolt

Since Specialization
Citations

This map shows the geographic impact of Daniel Perez‐Zsolt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Perez‐Zsolt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Perez‐Zsolt more than expected).

Fields of papers citing papers by Daniel Perez‐Zsolt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Perez‐Zsolt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Perez‐Zsolt. The network helps show where Daniel Perez‐Zsolt may publish in the future.

Co-authorship network of co-authors of Daniel Perez‐Zsolt

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Perez‐Zsolt. A scholar is included among the top collaborators of Daniel Perez‐Zsolt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Perez‐Zsolt. Daniel Perez‐Zsolt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tarrés-Freixas, Ferran, Eva Riveira‐Muñoz, Dàlia Raϊch‐Regué, et al.. (2025). A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model. mBio. 16(5). e0072025–e0072025. 3 indexed citations
2.
Resa‐Infante, Patricia, Itziar Erkizia, Federica Linty, et al.. (2024). Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy. Biomedicine & Pharmacotherapy. 175. 116726–116726. 4 indexed citations
3.
Du, Juan, Esperanza Cañas‐Ruano, Xavier Castells, et al.. (2023). Pan‐pox‐specific T‐cell responses in HIV‐1‐infected individuals after JYNNEOS vaccination. Journal of Medical Virology. 96(1). e29317–e29317. 6 indexed citations
4.
Raϊch‐Regué, Dàlia, Patricia Resa‐Infante, Marçal Gallemí, et al.. (2022). Role of Siglecs in viral infections: A double-edged sword interaction. Molecular Aspects of Medicine. 90. 101113–101113. 18 indexed citations
5.
Raϊch‐Regué, Dàlia, Jordana Muñoz‐Basagoiti, Daniel Perez‐Zsolt, et al.. (2022). Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern. Frontiers in Microbiology. 13. 810576–810576. 14 indexed citations
6.
Armario-Nájera, Victoria, Shilpa R. Shenoy, Yi Eve Sun, et al.. (2022). Physicochemical characterization of the recombinant lectin scytovirin and microbicidal activity of the SD1 domain produced in rice against HIV-1. Plant Cell Reports. 41(4). 1013–1023. 3 indexed citations
7.
Sachse, Martin, Raquel Tenorio, Isabel Fernández de Castro, et al.. (2022). Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis. Antiviral Research. 200. 105270–105270. 18 indexed citations
8.
Aza‐Pascual‐Salcedo, Mercedes, Jessica Bueno, Sonia Algarate, et al.. (2022). Randomized clinical trial to assess the impact of oral intervention with cetylpyridinium chloride to reduce salivary SARS‐CoV‐2 viral load. Journal Of Clinical Periodontology. 50(3). 288–294. 11 indexed citations
9.
Muñoz‐Basagoiti, Jordana, Daniel Perez‐Zsolt, Rubén León, et al.. (2021). Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro. Journal of Dental Research. 100(11). 1265–1272. 54 indexed citations
10.
Rodon, Jordi, Jordana Muñoz‐Basagoiti, Daniel Perez‐Zsolt, et al.. (2021). Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen. Frontiers in Pharmacology. 12. 646676–646676. 28 indexed citations
11.
Revollo, Boris, Ignacio Blanco, Nuria Izquierdo‐Useros, et al.. (2021). Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial. The Lancet Infectious Diseases. 21(10). 1365–1372. 51 indexed citations
12.
Muñoz‐Basagoiti, Jordana, Daniel Perez‐Zsolt, Jorge Carrillo, et al.. (2021). SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus. Membranes. 11(1). 64–64. 1 indexed citations
13.
Perez‐Zsolt, Daniel, Dàlia Raϊch‐Regué, Jordana Muñoz‐Basagoiti, et al.. (2021). HIV-1 trans-Infection Mediated by DCs: The Tip of the Iceberg of Cell-to-Cell Viral Transmission. Pathogens. 11(1). 39–39. 8 indexed citations
14.
Perez‐Zsolt, Daniel, Itziar Erkizia, Susana Benet, et al.. (2019). Dendritic Cells From the Cervical Mucosa Capture and Transfer HIV-1 via Siglec-1. Frontiers in Immunology. 10. 825–825. 35 indexed citations
15.
Perez‐Zsolt, Daniel, Itziar Erkizia, María Pino, et al.. (2019). Anti-Siglec-1 antibodies block Ebola viral uptake and decrease cytoplasmic viral entry. Nature Microbiology. 4(9). 1558–1570. 38 indexed citations
16.
Perez‐Zsolt, Daniel, Javier Martínez‐Picado, & Nuria Izquierdo‐Useros. (2019). When Dendritic Cells Go Viral: The Role of Siglec-1 in Host Defense and Dissemination of Enveloped Viruses. Viruses. 12(1). 8–8. 21 indexed citations
17.
Menezes‐Neto, Armando, Daniel Perez‐Zsolt, Ana Gámez‐Valero, et al.. (2018). Proteomics study of human cord blood reticulocyte-derived exosomes. Scientific Reports. 8(1). 14046–14046. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prasanna Bhat Breakdown of academic impact, for papers by Fatima Barmania Breakdown of academic impact, for papers by Marshall Karpel Breakdown of academic impact, for papers by Anjali Singh Breakdown of academic impact, for papers by Ramona Businger Breakdown of academic impact, for papers by Ralf Duerr Breakdown of academic impact, for papers by Frances Ayres Breakdown of academic impact, for papers by Inesa Hyseni Breakdown of academic impact, for papers by Isabel Pagani Breakdown of academic impact, for papers by Jialu Zhang
Rankless by CCL
2026